Healx company information, Employees & Contact Information

Healx and SCI Ventures Partner to Uncover Cures for Paralysis with AI-Driven Drug Discovery Genetic Engineering and Biotechnology News

Healx announces agreement with Sanofi to seek new rare disease indications for compound using AI drug discovery platform Business Wire

Healx and SCI Ventures partner to help treat paralysis using AI Home | Digital Health

History beckons as Healx doses first rare cancer patient with AI-created drug Business Weekly

Healx and Ovid Therapeutics to Enter Strategic Partnership GlobeNewswire

Healx: AI-driven drug repurposing for rare disease Pharmaceutical Technology

Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences Yahoo Finance

AI Company Raises €8.6M to Find Drugs for Rare Diseases Faster and Cheaper Than Ever Labiotech.eu

Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M TechCrunch

Healx doses first subject in Phase II neurofibromatosis type 1 therapy trial Clinical Trials Arena

AI Collaboration Between Sanofi and Healx Will Target Novel Rare Diseases Indications Genetic Engineering and Biotechnology News

Children's Tumor Foundation invests in Healx to advance Neurofibromatosis Type 1 treatments PR Newswire

U.K. drug discovery startup Healx taps GSK, Astex alum as CSO Fierce Biotech

Healx receives FDA clearance for Phase II trial of neurofibroma treatment Clinical Trials Arena

Healx COO on Channeling the Power of AI into Personalizing Medicine Labiotech.eu

Healx raises $56M Series B to use AI to find treatments for rare diseases TechCrunch

Boehringer Ingelheim pairs with AI firm Healx to repurpose assets for rare neurological disorders Fierce Biotech

Healx Candidate, SpringWorks Therapy Expand NF1 Treatment Options Genetic Engineering and Biotechnology News

AI Drug Discovery Company Healx Raises $47M, Cleared to Test Neurofibromatosis Drug Genetic Engineering and Biotechnology News

2022 was a breakthrough year for understanding rare diseases. 2023 needs to be better statnews.com

Healx: innovating drug discovery with AI and data AI Magazine

Healx Announces $47 million Series C Financing and FDA Clearance of Phase 2 IND for Neurofibromatosis Type 1 Trial Business Wire

Healx raises $56M to launch 40 rare disease R&D programs Fierce Biotech

Healx’s HLX-1502 awarded US orphan drug designation for neurofibromatosis type 1 BioWorld MedTech

Healx AI alliance with US-based Vuja De Sciences targets killer cancer recurrence Business Weekly

$40m 'Superman' backed fund partners with Healx to fight paralysis Business Weekly

Healx Healthtech Startup $56 Million Series B Pitch Deck VC Investors businessinsider.com

Healx: Clinical-Stage Biotech Company Secures $47 Million In Series C Pulse 2.0

Our Investment in Healx: revolutionising rare disease treatment discovery Atomico

Healx raises $47m Series C to progress AI-driven rare disease solution Business Weekly

Meet Meri Williams, the super CTO Sifted

Boehringer and Healx work together to target rare diseases The Pharma Letter

Healx and Sanofi unite to probe new disease indications Business Weekly

A snapshot of Healx PMLiVE

Healx to use AI platform Healnet to find COVID-19 treatments information-age.com

Healx – Generative AI Drug Discovery Amadeus Capital Partners

Cambridge drug discovery startup Healx raises £37m UKTN

Founder in Five: Q&A with Healx CEO Tim Guilliams UKTN

CTO Talk: Q&A with Healx’s Meri Williams verdict.co.uk

Coronavirus: AI steps up in battle against Covid-19 BBC

Healx secures $56m Series B UKTN

New HealX Foods Cauliflower Fries Grocery Business Magazine

Healx and Bit Bio engage patients with rare diseases for public webinar Cambridge Independent